Search
- Jun 13, 2023
- 4 min
HanAll Biopharma and Daewoong Pharmaceutical invest in Vincere Biosciences for Parkinson's Research
This partnership highlights the joining of forces across a shared mission to deliver disease-modifying medicines for Parkinson's disease.
- Jun 7, 2023
- 8 min
CERo Therapeutics to merge with SPAC and advance engineered T Cell therapeutics
Phoenix Biotech Acquisition Corp. (NASDAQ: PBAX) is a blank-check company formed for the purpose of effecting a merger, share exchange...
- May 26, 2023
- 4 min
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons
. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...
- May 12, 2023
- 6 min
Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction
Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate
- May 5, 2023
- 3 min
Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities
Through this partnership, the companies intend to facilitate faster clinical trial enrollment and provide patients with access to medicines